The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 13, 2020
Filed:
Mar. 26, 2018
Applicant:
Chase Therapeutics Corporation, Washington, DC (US);
Inventors:
Thomas N. Chase, Washington, DC (US);
Kathleen E. Clarence-Smith, Washington, DC (US);
Assignee:
CHASE THERAPEUTICS CORPORATION, Washington, unknown;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/428 (2006.01); A61P 25/16 (2006.01); A61K 31/4178 (2006.01); A61K 31/439 (2006.01);
U.S. Cl.
CPC ...
A61K 31/428 (2013.01); A61K 31/4178 (2013.01); A61K 31/439 (2013.01); A61P 25/16 (2018.01);
Abstract
The present invention describes the use of a 5HT3-antagonist, in combination with a 6-propylamino-4,5,6,7-tetrahydro-1,3-benzothiazole-2-amine, to reduce adverse effects and to facilitate the neuroprotective treatment of a patient suffering from a synucleinopathic disorder to enable a therapeutically effective 6-propylamino-4,5,6,7-tetrahydro-1,3-benzothiazole-2-amine daily dose without the dose-limiting adverse effects caused by pramipexole when administered alone.